Skip to main content
SpringerLink
Log in

Buprenorphine safer than methadone in pregnant women with opioid use disorder

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Wang S, et al. Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study. Drug Safety : 16 Jan 2023. Available from: URL: http://doi.org/10.1007/s40264-022-01267-z

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Buprenorphine safer than methadone in pregnant women with opioid use disorder. Reactions Weekly 1941, 9 (2023). https://doi.org/10.1007/s40278-023-32272-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-32272-9

Search

Navigation